Rocket Lab Corporation $RKLB Stock Purchased by ProShare Advisors LLC

Key Points

• ProShare Advisors increased its Rocket Lab stake by 7.5% in the third quarter to 578,195 shares valued at about $40.3 million. Institutional investors collectively own 71.78% of the company.
• Analyst sentiment remains generally positive, with a consensus rating of “Moderate Buy” and an average price target of $102.05, although some targets were recently lowered following concerns about Neutron’s development timeline.
• Rocket Lab continues to advance Neutron and its Electron launch business, but the company remains unprofitable and faces execution risks from the Neutron delay. Shares opened at $54.73, well below their 52-week high of $151.00.

ProShare Advisors LLC grew its stake in shares of Rocket Lab Corporation (NASDAQ:RKLB - Free Report) by 7.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 578,195 shares of the rocket manufacturer's stock after acquiring an additional 40,197 shares during the quarter. ProShare Advisors LLC owned about 0.10% of Rocket Lab worth $40,289,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Hilton Head Capital Partners LLC increased its stake in Rocket Lab by 3,590.0% during the 3rd quarter. Hilton Head Capital Partners LLC now owns 369 shares of the rocket manufacturer's stock valued at $26,000 after purchasing an additional 359 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in Rocket Lab in the second quarter worth about $30,000. Highland Investment Advisors LLC purchased a new position in Rocket Lab in the second quarter worth about $30,000. NBH Bank bought a new position in shares of Rocket Lab in the second quarter worth approximately $30,000. Finally, Cherry Tree Wealth Management LLC bought a new position in shares of Rocket Lab in the second quarter worth approximately $32,000. Hedge funds and other institutional investors own 71.78% of the company's stock.

Insiders Place Their Bets

In other Rocket Lab news, CAO Agostino Ricupati sold 669 shares of the business's stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $46,582.47. Following the completion of the sale, the chief accounting officer directly owned 26,863 shares in the company, valued at approximately $1,870,470.69. The trade was a 2.43% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marvin Clevenger sold 15,051 shares of the business's stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $1,048,001.13. Following the sale, the insider owned 458,924 shares of the company's stock, valued at approximately $31,954,878.12. This represents a 3.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 400,749 shares of company stock worth $26,964,474 in the last 90 days. Insiders own 8.40% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on RKLB shares. KeyCorp cut their price target on shares of Rocket Lab from $135.00 to $100.00 and set an "overweight" rating on the stock in a report on Thursday, October 15th. Cantor Fitzgerald reaffirmed a "mixed" rating and issued a $122.00 price objective on shares of Rocket Lab in a research report on Thursday, October 15th. Citigroup reiterated a "market outperform" rating on shares of Rocket Lab in a research note on Friday, October 16th. Wall Street Zen lowered Rocket Lab from a "hold" rating to a "sell" rating in a report on Saturday, August 15th. Finally, Needham & Company LLC restated a "buy" rating and issued a $120.00 price target on shares of Rocket Lab in a research note on Friday, October 16th. Three equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Rocket Lab has an average rating of "Moderate Buy" and a consensus target price of $102.05.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab continues to make operational progress: Neutron’s second stage and thrust module have reached Wallops Island, Virginia, for ground testing, while the company is preparing to ship its 100th Electron rocket. These milestones suggest development is advancing despite the launch delay. RKLB Stock Tests Bulls’ Patience
• Positive Sentiment: Analysts and bullish investors continue to point to Rocket Lab’s expanding business, including strong revenue growth, a reported $2.36 billion backlog, NASA-related opportunities, Iridium work and Mynaric exposure. Some forecasts argue that a successful Neutron milestone could eventually prompt a significant re-rating toward $100. Price Prediction: Rocket Lab Stock Will Hit $100
• Neutral Sentiment: The bullish investment thesis remains intact for some investors, but the Neutron delay changes the expected timing of revenue, launches and potential profitability. Rocket Lab’s substantial cash position and low leverage provide flexibility, though its high-growth valuation leaves the stock sensitive to schedule changes. The Neutron Delay Changes the Timeline, Not the Thesis
• Negative Sentiment: Investors are concerned that manufacturing defects in Neutron’s carbon-fiber structures—likened to trapped bubbles in a layered cake—contributed to the schedule slip. The delay increases execution risk and could lead to additional spending or dilution if development takes longer than expected. Rocket Lab Stock Lost Its Launch Date
• Negative Sentiment: An analyst fair-value estimate was trimmed from approximately $105.05 to $102.15, reflecting lower near-term expectations and greater execution risk following the Neutron delay. With Rocket Lab still unprofitable, investors are placing greater emphasis on delivery milestones rather than current earnings. Rocket Lab Fair Value Trim After Neutron Delay

Rocket Lab Stock Performance

Shares of NASDAQ RKLB opened at $54.73 on Monday. The firm's 50-day moving average price is $64.23 and its 200-day moving average price is $79.93. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01. The company has a market cap of $32.75 billion, a PE ratio of -202.70 and a beta of 3.15. Rocket Lab Corporation has a 52-week low of $37.57 and a 52-week high of $151.00.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last announced its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). The company had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. As a group, analysts anticipate that Rocket Lab Corporation will post -0.20 EPS for the current year.

Rocket Lab Profile

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab's launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.

Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.